|Day Low/High||151.56 / 153.40|
|52 Wk Low/High||117.10 / 160.68|
Despite tepid market reaction, and analyst skepticism, there might be some upside for TMO.
The potential transaction could be a true game-changer that makes sense strategically and financially, albeit dilutive near term.
The major indices hit new highs this week as stocks maintained their shine. In the portfolio, we exited 2 positions and added a name.
The jobs report helps the market end the week on a high note. Two of our portfolio positions get bigger.
AACC 2016 - Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, will exhibit its expanded offering of new assays, instruments and software at the 2016 American Association of Clinical...
Lots of earnings (nice work, tech) and a Fed meeting make for a busy week. In the portfolio, we've taken out our Target.
Zimmer Biomet is on track to return to growth, which could signal more mergers and acquisitions within the industry.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter of 2016, ended July 2, 2016.
The most recent short interest data has been released for the 07/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Stocks have an up-and-down week as the earnings floodgates open. Portfolio moves include cutting one position.
Stocks kept climbing this week as earnings season got into high gear. We cut one name from the portfolio and rerated a few holdings.
Trade-Ideas LLC identified Thermo Fisher Scientific (TMO) as a momo momentum candidate
We adjusted our holdings this week in four portfolio names, adding to Comcast and Visa but trimming Costco and Walgreens.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.
Goldman Sachs expects "rising uncertainty" in the second half of 2016 and suggests that investors stick to stocks within defensive sectors including consumer, health care and telecom services.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2016 before the market opens on Thursday, July 28, 2016, and will...
Stocks showed resilience after the Brexit-related decline. We took advantage of the selloff to make several portfolio moves.
Cramer says you're in good shape with Dominion Resources, but he is avoiding Freeport-McMoRan.
Investors re-evaluated what stocks are actually worth and started buying, Cramer says.
We remained quiet this week when it came to trading in light of an economy on fragile ground and the coming Brexit vote, but did downgrade our rating on Costco after its recent run-up.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a partnership with West China Hospital of Sichuan University, one of the largest single-site hospitals in the world, to...
Global growth concerns sapped the market's strength this week. We added to 2 positions in the portfolio.
KeyBanc Capital Markets analyst Matthew Mishan ups his price target for maker of scientific instrument maker.